Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy
Catheter Precision has secured a US patent allowance for its LockeT technology, a suture retention device for wound closure after percutaneous venous punctures. The patent strengthens the company's intellectual property position and supports its long-term growth strategy.
Catheter Precision, a US-based medical device company, has received a Notice of Allowance from the US Patent and Trademark Office for its proprietary LockeT technology. The patented system enables precise control of suture tension and pressure application after vascular procedures. The company believes its expanding patent portfolio will support long-term commercialization and product development. LockeT is a Class 1 device registered with the FDA and has received CE Mark approval. Catheter Precision focuses on developing groundbreaking technology for electrophysiology procedures. The patent allowance reinforces the company's competitive position in complex procedural markets.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.